Southwest MS Nephrology — Brookhaven, Mississippi

Southwest MS Nephrology is a clinical research site located in Brookhaven, Mississippi, United States 39601.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Southwest MS Nephrology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Type 2 Diabetes Mellitus, Chronic Kidney Diseases.

Sponsors: Prokidney.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Brookhaven

Browse all research sites in Mississippi · View every site in Brookhaven

• Research Site
• Southwest Mississippi Nephrology PLLC
• Fresenius Kidney Care
• Investigational Site
• Research Center
• Cara Therapeutics Study Site
• Fresenius Kidney Care Brookhaven ( Site 0693)
• OPKO Investigative Site
• Ardelyx Investigative Site 409
• Kings Daughters Med Ctr
• Research Facility

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Southwest MS Nephrology?

Southwest MS Nephrology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Southwest MS Nephrology conducted?

Southwest MS Nephrology has 1 clinical trials on record, with 1 currently active. Their work covers Type 2 Diabetes Mellitus, Chronic Kidney Diseases.

Is Southwest MS Nephrology accredited by Crixeo Clinical Trials?

Southwest MS Nephrology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Southwest MS Nephrology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.